Status:
RECRUITING
Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy
Lead Sponsor:
Ain Shams University
Conditions:
Dexmedetomidine
Adjuvant
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.
Detailed Description
Scalp block is proposed as a multimodal approach to preventing postoperative pain and hemodynamic responses to previous noxious stimulation during the operation. The use of adjuvants, such as dexmede...
Eligibility Criteria
Inclusion
- Age from 18 to 65 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Undergoing supratentorial elective planned craniotomies.
Exclusion
- Patients refusal.
- History of known allergy to the used local anesthetic or dexmedetomidine.
- Bleeding disorders.
- Evidence of local infection at the site of injection.
- Emergency craniotomy.
- Psychotic disorder.
- Patients who will not be extubated in the operating room after surgery.
Key Trial Info
Start Date :
May 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06993922
Start Date
May 29 2025
End Date
November 1 2025
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11591